MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,755,000 | -83.9% | 115,100 | -88.3% | 1.35% | -81.9% |
| Q2 2019 | $35,844,000 | -66.1% | 982,831 | -74.0% | 7.50% | -67.6% |
| Q1 2019 | $105,616,000 | +46.0% | 3,778,742 | 0.0% | 23.17% | +1.6% |
| Q4 2018 | $72,325,000 | -36.0% | 3,778,742 | 0.0% | 22.80% | -24.4% |
| Q3 2018 | $113,022,000 | -18.5% | 3,778,742 | 0.0% | 30.15% | +33.9% |
| Q2 2018 | $138,680,000 | +24.8% | 3,778,742 | +12.0% | 22.51% | -50.1% |
| Q1 2018 | $111,119,000 | +32.2% | 3,373,397 | +9.7% | 45.08% | -8.4% |
| Q4 2017 | $84,080,000 | -40.8% | 3,075,302 | -19.8% | 49.24% | -33.3% |
| Q3 2017 | $142,012,000 | +7.3% | 3,833,999 | +10.1% | 73.83% | -11.5% |
| Q2 2017 | $132,340,000 | -29.4% | 3,481,699 | -9.2% | 83.44% | -4.5% |
| Q1 2017 | $187,482,000 | – | 3,833,999 | – | 87.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |